These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
807 related items for PubMed ID: 19438435
1. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease. Chen S, Nakahara T, Uchi H, Takeuchi S, Takahara M, Kido M, Dugu L, Tu Y, Moroi Y, Furue M. Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435 [Abstract] [Full Text] [Related]
2. Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2. Chen SJ, Nakahara T, Takahara M, Kido M, Dugu L, Uchi H, Takeuchi S, Tu YT, Moroi Y, Furue M. Br J Dermatol; 2009 Feb; 160(2):442-5. PubMed ID: 19016696 [Abstract] [Full Text] [Related]
3. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ. Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679 [Abstract] [Full Text] [Related]
4. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides. Levidou G, Siakantaris M, Papadaki T, Papadavid E, Vassilakopoulos TP, Angelopoulou MK, Marinos L, Nikolaou V, Economidi A, Antoniou C, Patsouris E, Korkolopoulou P. J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026 [Abstract] [Full Text] [Related]
5. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats. Hu LY, Sun ZG, Wen YM, Cheng GZ, Wang SL, Zhao HB, Zhang XR. Neuroscience; 2010 Sep 01; 169(3):1046-62. PubMed ID: 20678995 [Abstract] [Full Text] [Related]
6. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Nathan CO, Amirghahari N, Abreo F, Rong X, Caldito G, Jones ML, Zhou H, Smith M, Kimberly D, Glass J. Clin Cancer Res; 2004 Sep 01; 10(17):5820-7. PubMed ID: 15355912 [Abstract] [Full Text] [Related]
7. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas. Korkolopoulou P, Levidou G, El-Habr EA, Piperi C, Adamopoulos C, Samaras V, Boviatsis E, Thymara I, Trigka EA, Sakellariou S, Kavantzas N, Patsouris E, Saetta AA. Histopathology; 2012 Aug 01; 61(2):293-305. PubMed ID: 22690797 [Abstract] [Full Text] [Related]
8. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Amornphimoltham P, Patel V, Sodhi A, Nikitakis NG, Sauk JJ, Sausville EA, Molinolo AA, Gutkind JS. Cancer Res; 2005 Nov 01; 65(21):9953-61. PubMed ID: 16267020 [Abstract] [Full Text] [Related]
9. Expression of insulin-like growth factor-1 receptor, p-AKT and p-ERK1/2 protein in extramammary Paget's disease. Liu H, Moroi Y, Yasumoto S, Kokuba H, Imafuku S, Koga T, Masuda T, Tu Y, Furue M, Urabe K. Br J Dermatol; 2006 Sep 01; 155(3):586-91. PubMed ID: 16911286 [Abstract] [Full Text] [Related]
10. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas. Lin F, Zhang PL, Yang XJ, Prichard JW, Lun M, Brown RE. Ann Clin Lab Sci; 2006 Sep 01; 36(3):283-93. PubMed ID: 16951269 [Abstract] [Full Text] [Related]
11. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma. Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA. BJU Int; 2012 Dec 01; 110(11 Pt C):E1237-48. PubMed ID: 23107319 [Abstract] [Full Text] [Related]
12. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors. Yamada Y, Kohashi K, Fushimi F, Takahashi Y, Setsu N, Endo M, Yamamoto H, Tokunaga S, Iwamoto Y, Oda Y. Cancer; 2014 Mar 15; 120(6):864-76. PubMed ID: 24353015 [Abstract] [Full Text] [Related]
13. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Zhou X, Tan M, Stone Hawthorne V, Klos KS, Lan KH, Yang Y, Yang W, Smith TL, Shi D, Yu D. Clin Cancer Res; 2004 Oct 15; 10(20):6779-88. PubMed ID: 15501954 [Abstract] [Full Text] [Related]
14. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM. Cancer Res; 2007 May 01; 67(9):4287-94. PubMed ID: 17483341 [Abstract] [Full Text] [Related]
15. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S. Cancer; 2006 Oct 15; 107(8):1801-11. PubMed ID: 16983702 [Abstract] [Full Text] [Related]
16. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas. Dobashi Y, Suzuki S, Kimura M, Matsubara H, Tsubochi H, Imoto I, Ooi A. Hum Pathol; 2011 Feb 15; 42(2):214-26. PubMed ID: 21040950 [Abstract] [Full Text] [Related]
17. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F. Invest Ophthalmol Vis Sci; 2010 Jan 15; 51(1):421-9. PubMed ID: 19661225 [Abstract] [Full Text] [Related]
18. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells. Fang CX, Yang X, Sreejayan N, Ren J. Exp Neurol; 2007 Jan 15; 203(1):196-204. PubMed ID: 16962100 [Abstract] [Full Text] [Related]
19. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma. Feng W, Brown RE, Trung CD, Li W, Wang L, Khoury T, Alrawi S, Yao J, Xia K, Tan D. Ann Clin Lab Sci; 2008 Jan 15; 38(3):195-209. PubMed ID: 18715846 [Abstract] [Full Text] [Related]
20. Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma. Setsu N, Kohashi K, Fushimi F, Endo M, Yamamoto H, Takahashi Y, Yamada Y, Ishii T, Yokoyama K, Iwamoto Y, Oda Y. Cancer; 2013 Oct 01; 119(19):3504-13. PubMed ID: 23861137 [Abstract] [Full Text] [Related] Page: [Next] [New Search]